Li Med Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.10 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 M
- Revenue Growth 73.28%
- Profit Growth 188.25%
- Ebitda 169.66%
- Net Worth 84.56%
- Total Assets 83.07%
About Li Med Labs
Li Med Labs Private Limited (LMLPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 June 2018 (Six years and seven months 28 days old ). Its registered office is in Thiruvananthapuram, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹7.50 M.
Ramanath Ganesh, Vadakkencherry Sangeetha, Gopalakrishnapillai Anish, and Seven other members serve as directors at the Company.
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999KL2018PTC053797
- Company No.
053797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Li Med Labs?
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shafi Ayush  | Whole-Time Director | 05-Feb-2019 | Current |
| Ramanath Ganesh | Whole-Time Director | 26-Jun-2018 | Current |
| Vadakkencherry Sangeetha | Director | 26-Jun-2018 | Current |
| Gopalakrishnapillai Anish | Whole-Time Director | 05-Feb-2019 | Current |
| Venpala Kavitha | Director | 05-Feb-2019 | Current |
| Mithun Anver | Whole-Time Director | 05-Feb-2019 | Current |
Financial Performance of Li Med Labs.
Li Med Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 73.28% increase. The company also saw a substantial improvement in profitability, with a 188.25% increase in profit. The company's net worth Soared by an impressive increase of 84.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Li Med Labs?
In 2023, Li Med Labs had a public holding of 81.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Li Med Pharma Private LimitedRamanath Ganesh, Gopalakrishnapillai Anish and 3 more are mutual person
Charges (Loans)
₹7.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2020 | Others | ₹7.50 M | Open |
How Many Employees Work at Li Med Labs?
Unlock and access historical data on people associated with Li Med Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Li Med Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Li Med Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
